首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1623192

全球支氣管內導管市場規模（按產品、應用、地區、範圍和預測）

Global Endobronchial Tubes Market Size By Product (Single Use/Disposable, Reusable), By Application (Hospitals, Ambulatory Surgical Clinics), By Geographic Scope And Forecast

出版日期: 2024年07月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

支氣管內管市場規模及預測

2024 年支氣管內管市場規模價值為 21.8 億美元，預計到 2031 年將達到 35.5 億美元，2024 年至 2031 年的複合年增長率為 6.3%。促進支氣管內導管市場成長的主要因素包括由於心血管疾病、呼吸系統疾病、糖尿病、癌症和其他肺部損傷等慢性呼吸系統疾病的日益流行導致手術數量的增加。全球支氣管內管市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

支氣管內導管的全球市場驅動因子

支氣管內管市場的市場推動因素可能受到多種因素的影響。

呼吸系統疾病發生率增加

隨著氣喘、肺癌、慢性阻塞性肺病（COPD）等呼吸系統疾病在世界各地的發生率不斷上升，支氣管插管在治療和診斷方面越來越必不可少，越來越受歡迎。

技術開發：

新型塗層的創造、更大的移動性和更好的可視性特徵以及支氣管內管設計和材料的其他發展正在推動市場的發展。這些發展所帶來的患者治療效果的改善和程序效率的提高促使採用率的提高。

老年人口不斷增加：

由於世界人口老化，人們更容易患呼吸系統疾病，對支氣管內管的需求日益增加。老年人對治療呼吸系統疾病的醫療幹預需求普遍存在，這推動了市場的擴張。

對微創治療的需求不斷增加：

支氣管內管廣泛應用於內視鏡肺減容術、支氣管鏡檢查等微創手術。隨著微創治療的流行，其具有恢復更快、併發症更少等優勢，預計對支氣管內管的需求將會飆升。

增加用途：

支氣管內導管的用途越來越多地除傳統的診斷和治療目的之外。其在安寧療護和臨終關懷、研究、培訓和教育中的應用日益廣泛，擴大了市場潛力。

政府資金與措施：

由於政府的資助和改善醫療保健系統以及提高公眾對呼吸系統疾病認識的舉措，市場正在成長。呼吸照護相關研究和開發計畫的資助也促進了支氣管插管技術的進步。

增加醫療支出：

醫療保健支出的增加推動了支氣管內插管等尖端醫療技術的採用，尤其是在新興國家。醫療保健基礎設施的改善和可支配收入的增加使患者能夠獲得尖端的診斷和治療方法，從而推動了市場擴張。

夥伴關係與合作關係：

合作夥伴關係和協作促進了醫療器材製造商、研究中心和醫療機構之間的技術轉移，從而加快了產品開發。策略合作夥伴關係使公司能夠更有效地解決未滿足的醫療需求並提高其市場佔有率。

教育與教育活動：

醫療保健和倡導組織正在進行公眾意識運動和教育計劃，以提高公眾對呼吸系統疾病和各種可用治療方法（包括支氣管內插管）的瞭解。人們的認識不斷提高，推動了早期診斷和治療，從而促進了市場的發展。

限制全球支氣管內管市場的因素

有幾個因素可能會對支氣管內管市場造成限製或課題。

氣管插管成本高：

在資源匱乏的貧窮國家，支氣管插管的費用可能超出了醫療機構的負擔能力。此類專業醫療設備的引進可能會因其前期成本過高而受到阻礙，尤其是在資金緊張的地區。

限時兌換規則：

報銷規定薄弱阻礙了支氣管內手術和相關設備市場的擴張。不同地區和醫療體系的報銷率差異可能會影響患者和醫護人員對支氣管內導管的可負擔性和可近性。

複雜的監理環境：

醫療器材審批和商業化的嚴格規定可能會使新的支氣管內管產品難以進入市場。由於必須遵守多個國家不同的監管框架，因此開發和推出產品的過程變得更具課題性且耗時。

技術課題與成果：

支氣管內手術技術複雜，容易出現出血、感染、氣道損傷等後果。與管道放置、導航和維護有關的技術問題可能會阻礙實施，尤其是對於缺乏經驗的醫療保健提供者。

限制熟練員工的取得：

支氣管內手術需要專門的訓練和知識。由於缺乏合格的肺部疾病專家、介入專家和熟練先進支氣管鏡技術的呼吸治療師，支氣管內插管和相關程序不太可能被廣泛採用。

感染控制問題：

由於支氣管內管是可重複使用的醫療設備，因此每次使用後徹底清潔和消毒以防止感染擴散非常重要。有關不良消毒程序和潛在交叉污染的問題可能會危及患者安全並降低對支氣管內管產品的信心。

替代療法：

根據臨床情況，藥物治療、肺部復健和手術治療是支氣管內置入的有效替代方案。替代療法的出現可能會減少對支氣管內管的需求，特別是在治療較不嚴重的呼吸系統疾病時。

法律與道德問題：

當對高風險患者（例如需要安寧療護或患有嚴重肺部疾病的患者）使用支氣管內導管時，醫療保健提供者和患者可能會基於道德問題做出決定。市場動態也可能受到不利事件或問題的法律後果的影響。

Endobronchial Tubes Market size was valued at USD 2.18 Billion in 2024 and is projected to reach USD 3.55 Billion by 2031, growing at a CAGR of 6.3% from 2024 to 2031. The major factor that contributes to the growth of the Endobronchial Tubes Market includes an increase in the number of surgical procedures because of the growing popularity of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. The Global Endobronchial Tubes Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Endobronchial Tubes Market Drivers

The market drivers for the Endobronchial Tubes Market can be influenced by various factors. These may include:

Rising Incidence of Respiratory disorders:

Endobronchial tubes are becoming more and more necessary for both therapeutic and diagnostic purposes as the prevalence of respiratory disorders like asthma, lung cancer, and chronic obstructive pulmonary disease (COPD) climbs globally.

Technological Developments:

The creation of novel coatings, more mobility, and better visibility features, among other developments in endobronchial tube design and materials, are propelling market expansion. The improvements in patient outcomes and procedure efficiency brought about by these developments lead to higher adoption rates.

Growing Aging Population:

The need for endobronchial tubes is being driven by the aging population worldwide, which is more susceptible to respiratory conditions. The need for medical interventions to treat respiratory disorders in the elderly is common, which is driving expansion in the market.

Growing Need for Less Invasive Treatments:

Endobronchial tubes are widely utilized in less invasive treatments including endoscopic lung volume reduction and bronchoscopy. The need for endobronchial tubes is anticipated to soar as a result of a growing inclination towards minimally invasive procedures because of advantages including quicker recovery and a decreased chance of problems.

Increasing Uses:

Endobronchial tubes are being used for purposes other than the conventional diagnostic and therapeutic ones. Their market potential is being expanded by the growing use of them in palliative care and end-of-life interventions, as well as in research, training, and educational contexts.

Government Funding and Initiatives:

The market is growing as a result of government funding and initiatives to upgrade the healthcare system and raise public awareness of respiratory illnesses. Financing for respiratory care-related R&D initiatives encourages endobronchial tube technology advancement as well.

Growing Healthcare Expenditure:

The adoption of cutting-edge medical technologies like endobronchial tubes is aided by rising healthcare spending, especially in emerging nations. Patients may now access cutting-edge diagnostic and therapeutic procedures because to improved healthcare infrastructure and increased disposable incomes, which is propelling market expansion.

Partnerships and Collaborations:

Partnerships and collaborations promote technology transfer and quicken product development amongst medical device producers, research centers, and healthcare institutions. Companies can more efficiently address unmet medical needs and broaden their market presence by forming strategic partnerships.

Initiatives for Public Awareness and Education:

Healthcare organizations and advocacy groups run public awareness campaigns and educational programs to increase public knowledge of respiratory disorders and the range of treatments available, including endobronchial tubes. Growing awareness promotes early diagnosis and treatment, which propels the market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Endobronchial Tubes Market Restraints

Several factors can act as restraints or challenges for the Endobronchial Tubes Market. These may include:

Exorbitant Cost of Endobronchial Tubes:

In impoverished nations with little funding, the expense of endobronchial tubes can be unaffordable for medical facilities. Adoption of these specialized medical devices may be hampered by their high initial cost, particularly in environments where financial limitations are an issue.

Limited Reimbursement rules:

The expansion of the endobronchial procedure and related equipment market is hindered by inadequate reimbursement rules. The pricing and accessibility of endobronchial tubes for patients and healthcare professionals may be impacted by variations in reimbursement rates across different areas and healthcare systems.

Complicated Regulatory Environment:

New endobronchial tube products may find it difficult to enter the market because to the strict regulations controlling the approval and commercialization of medical devices. The process of developing and launching a product is made more difficult and time-consuming by the need to comply with various regulatory frameworks in several nations.

Technical Difficulties and consequences:

Endobronchial surgeries are technically complex and have a predisposition to consequences such bleeding, infection, and airway damage. Adoption may be hampered by technical issues with tube installation, navigation, and maintenance, especially for less seasoned medical professionals.

Restricted Access to Skilled Personnel:

Endobronchial surgeries necessitate specialized training and knowledge. Endobronchial tubes and associated operations may not be widely adopted due to a lack of qualified pulmonologists, interventionalists, and respiratory therapists who are experienced in sophisticated bronchoscopic techniques.

Issues with Infection Control:

Because endobronchial tubes are reusable medical equipment, it is important to thoroughly clean and sterilize them in between usage to stop the spread of infection. Issues regarding insufficient sterilization procedures or the potential for cross-contamination could compromise patient safety and diminish confidence in endobronchial tube products.

Alternative Treatment modalities:

In some clinical situations, medication, pulmonary rehabilitation, and surgical therapies are effective substitutes for endobronchial procedures. The need for endobronchial tubes may be curtailed by the availability of substitute therapies, especially for less severe respiratory diseases.

Legal and Ethical Issues:

When using endobronchial tubes in patients who are at risk, such as those who require palliative care or have severe lung illness, medical professionals and patients may make decisions based on ethical concerns. Market dynamics may also be impacted by legal ramifications of unfavorable incidents or issues.

Global Endobronchial Tubes Market Segmentation Analysis

The Global Endobronchial Tubes Market is Segmented on the basis of Product, Application, And Geography.

Endobronchial Tubes Market, By Product

Single Use/Disposable
Reusable

Based on Product, The market is segmented into Single Use/Disposable and Reusable. The Single Use/Disposable segment holds the big market share. This is because it will help in the prevention of infection among various humans and these pipes are biodegradable also and also do not affect the environment too.

Endobronchial Tubes Market, By Application

Hospitals
Ambulatory Surgical Clinics
Specialty Clinics

Based on Application, The market is segmented into Hospitals, Ambulatory Surgical Clinics, and Specialty Clinics. The hospital segment accounted for the largest share of market revenue, and this is expected to continue throughout the forecast period. The global Endobronchial Tubes Market is expected to grow due to advancements in coated endotracheal tubes, an increase in the incidence of ventilator-associated pneumonia, increased awareness of technologically advanced endotracheal tubes, and developments in the fields of nano-bio application and drug design.

Endobronchial Tubes Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Endobronchial Tubes Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America led the market, accounting for the largest share, and this trend is expected to continue throughout the forecast period. The rise in demand for coated endotracheal tubes in such disorders is a significant reason that contributes to the growth of the Endobronchial Tubes Market. This is related to the growing cases of pulmonary ailments, pneumonia, cancer, and other conditions.

Key Players

The "Global Endobronchial Tubes Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
Sonoma Pharmaceuticals Inc., Teleflex Incorporated, Venner Medical GmbH, Enox Biopharma Inc., Hospiteknik Healthcare, Innovative Surface Technologies, Inc., Bactiguard Holding AB, C. R. Bard, Inc., N8 Medical, LLC, and Sharklet Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL ENDOBRONCHIAL TUBES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ENDOBRONCHIAL TUBES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY PRODUCT

5.1 Overview
5.2 Single Use/Disposable
5.3 Reusable

6 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY APPLICATION

6.1 Overview
6.2 Hospitals
6.3 Ambulatory Surgical Clinics
6.4 Specialty Clinics

7 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East & Africa

8 GLOBAL ENDOBRONCHIAL TUBES MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Sonoma Pharmaceuticals Inc
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Teleflex Incorporated
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Venner Medical GmbH
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Enox Biopharma Inc
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Hospiteknik Healthcare
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Innovative Surface Technologies, Inc
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Bactiguard Holding AB
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 C. R. Bard, Inc
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 N8 Medical, LLC
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Sharklet Technologies, Inc
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments